Skip to main content

Table 1 Summary of the 20 randomised controlled trials

From: Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?

 

Trial name

Trial population

Age range (years)

Outcome measures

No. of outcomes

Time points post-randomisation

No. of time points

No. of correlations

Sample size at baseline

Max Na

Reference

Year of publication

1

Leg Ulcer

Leg ulcers

32 to 97

EQ-5D, SF-36

9

3, 12 months

2

18

233

200

[9]

1998

2

NAMEIT

Early severe rheumatoid arthritis

18 to 75

SF-36, SF-6D

9

2, 4, 6, 8, 10, 12 months

6

54

222

222

[10]

2000

3

Homeopathy for CFS

Chronic fatigue syndrome (CFS)

20 to 62

MFI

5

6 months

1

5

103

85

[11]

2004

4

Acupuncture

Low back pain

20 to 64

SF-36

8

3, 12, 24 months

3

24

239

217

[12]

2005

5

Knee Replacement

Osteoarthritis patients undergoing total knee replacement

51 to 92

SF-36, WOMAC

14

3 months

1

14

151

114

[13]

2005

6

FED

Older (aged ≥ 65) hospitalised patients with acute illness

65 to 93

Barthel, SF-36

9

1.5, 6 months

2

18

445

225

[14]

2006

7

AIM-High

Malignant melanoma

18 to 77

EORTC QLQ-C30

15

6, 12, 18, 24 months

4

60

444

392

[15]

2006

8

PoNDER

New mothers

18 to 45

CORE-OM, EPDS,b SF-36, SF-6D

9

4.5, 10.5, 16.5 months

3

26

2659

2659

[16]

2009

9

COPD

Chronic obstructive pulmonary disease (COPD)

49 to 86

EQ-5D, SF-36, SF-6D

12

2, 6, 12, 18 months

4

48

238

172

[17]

2010

10

Corn Plasters

Foot corns

18 to 90

EQ-5D, EQ-5D VAS, VAS Pain

3

3, 6, 9, 12 months

4

12

201

182

[18]

2013

11

PLINY

Independently living older people (aged ≥ 75)

75 to 95

EQ-5D, EQ-5D VAS, GSES, ONS Well-being, PHQ-9, SF-36

15

6 months

1

15

157

56

[19]

2014

12

3Mg

Adults with acute severe asthma in the emergency department

16 to 88

EQ-5D

1

1 month

1

1

932

437

[20]

2014

13

SELF

Shoulder rotator cuff tendinopathy

23 to 83

SPADI

3

3, 6, 12 months

3

9

85

59

[6]

2016

14

BEADS

Post-stroke depression

31 to 97

EQ-5D, EQ-5D VAS, PHQ-9

3

6 months

1

3

49

39

[21]

2016

15

DiPALS

Amyotrophic lateral sclerosis (ALS)

23 to 83

EQ-5D, SAQLI, SF-36

13

2, 3, 6, 9, 12 months

5

65

74

55

[22]

2016

16

Lifestyle Matters

Independently living older people (aged ≥ 65)

65 to 92

EQ-5D, EQ-5D VAS, GSES, PHQ-9, SF-36

14

6, 24 months

2

28

288

262

[23]

2017

17

IPSU

Women with urinary incontinence and sexual dysfunction

21 to 70

EQ-5D, PISQ-31, SF-36

15

6 months

1

15

107

66

[24]

2018

18

POLAR

Lumbar radicular syndrome (LRS)

23 to 71

Back Pain VAS, EQ-5D, EQ-5D VAS, Leg Pain VAS, ODI

5

1.5, 3, 6 months

3

15

80

73

[25]

2018

19

PRACTICE

COPD

40 to 92

EQ-5D, EQ-5D VAS

2

0.25, 1, 3 months

3

6

55

42

[26]

2018

20

STEPWISE

Schizophrenia

18 to 71

B-IPQ, BPRS, EQ-5D, EQ-5D VAS, PHQ-9, RAND SF-36

14

3, 12 months

2

28

412

358

[27]

2018

        

464

7173

5915

  
  1. aMax N is the maximum sample size for the baseline and post-randomisation follow-up correlations
  2. bFor the PoNDER trial the EPDS was measured at baseline and at 4.5 and 10.5 months post-randomisation
  3. Abbreviations: Barthel Barthel Index for Activities of Daily Living (ADL), B-IPQ Brief Illness Perception Questionnaire, BPRS Brief Psychiatric Rating Scale, CORE-OM Clinical Outcomes in Routine Evaluation-Outcome Measure, EORTC QLQ European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire, EPDS Edinburgh Postnatal Depression Scale, EQ-5D EuroQol Five Dimension, GSES General Self-Efficacy Scale, MFI Multidimensional Fatigue Inventory, ODI Oswestry Disability Index, ONS Office for National Statistics Well-being Questionnaire, PHQ-9 Patient Health Questionnaire, PISQ-31 Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, RAND SF-36 Research and Development 36-item Short Form Survey Instrument, SAQLI Sleep Apnea Quality of Life Index, SF-36 Short Form (36 item) Health Survey, SF-6D Short Form Six Dimension, SPADI Shoulder Pain and Disability Index, VAS visual analogue scale, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index